5 mrt. 2024 · Compare risks and benefits of common medications used for Tardive Dyskinesia. Find the most popular drugs, view ratings and user reviews.

Tardive Dyskinesia Tardive dyskinesia is a movement disorder that can develop if you take an antipsychotic medication and/or other types of medications. It’s typically not reversible, but treatment …

9 dec. 2025 · Tardive dyskinesia (TD) is a movement disorder characterized by involuntary, repetitive movements. These movements typically appear following prolonged use of medications that block …

6 okt. 2025 · INTRODUCTION Tardive dyskinesia (TD) is a medication-induced hyperkinetic movement disorder associated with the use of dopamine receptor-blocking agents, including first- and second …

14 mei 2025 · The Clinician’s Tardive Inventory (CTI): a new clinical tool for documenting and rating tardive dyskinesia. J Clin Psychiatry. 2024;85 (1):23m14886. 12. Farber RH, Stull DE, Witherspoon B, …

17 dec. 2019 · Two medications are FDA-approved to treat tardive dyskinesia, and new long-term evidence has been reported. Follow along as expert Joseph P. McEvoy, MD, reviews the evidence.

25 okt. 2024 · Our easy-to-read patient fact sheet provides clinicians with information on drugs for tardive dyskinesia and other management strategies.

25 sep. 2025 · Best Treatments for Tardive Dyskinesia (TD) VMAT2 inhibitors (valbenazine or deutetrabenazine) are the first-line treatments for tardive dyskinesia while maintaining appropriate …

19 aug. 2024 · Background Tardive dyskinesias (TDs) are involuntary movements of the tongue, lips, face, trunk, and extremities that occur in patients treated with long-term dopaminergic antagonist …

Data on tardive dyskinesia treatment are limited, and the best management strategy remains prevention. More long-term safety and efficacy data are needed for deutetrabenazine and valbenazine, and their …